Key Points
- Director R Janet Whitmore purchased 10,000 shares of Solesence (NASDAQ:SLSN) on Nov. 19 at $1.92, bringing her holdings to 2,084,198 shares (a 0.48% increase); she also made additional buys Nov. 14–18, totaling roughly 35,000 shares acquired in the period.
- Solesence stock traded around $2.05 with a market cap of ~$144.6M, a 52-week range of $1.34–$16.56, a 50-day/200-day SMA of $2.87/$3.47, and a stretched P/E of 205.21, indicating low recent price levels versus last year’s highs.
- Institutional investors own about 70.22% of the company, with Vanguard and JPMorgan among recent buyers, while analyst coverage is sparse and the consensus rating is a "Sell".
Solesence, Inc. (NASDAQ:SLSN - Get Free Report) Director R Janet Whitmore purchased 10,000 shares of Solesence stock in a transaction dated Wednesday, November 19th. The stock was bought at an average price of $1.92 per share, for a total transaction of $19,200.00. Following the completion of the purchase, the director owned 2,084,198 shares in the company, valued at $4,001,660.16. This represents a 0.48% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
R Janet Whitmore also recently made the following trade(s):
- On Tuesday, November 18th, R Janet Whitmore purchased 267 shares of Solesence stock. The shares were bought at an average cost of $1.83 per share, for a total transaction of $488.61.
- On Monday, November 17th, R Janet Whitmore acquired 5,000 shares of Solesence stock. The shares were bought at an average price of $1.87 per share, with a total value of $9,350.00.
- On Friday, November 14th, R Janet Whitmore acquired 19,789 shares of Solesence stock. The stock was bought at an average cost of $1.73 per share, with a total value of $34,234.97.
Solesence Price Performance
Solesence stock traded down $0.14 during mid-day trading on Friday, reaching $2.05. The company had a trading volume of 6,247 shares, compared to its average volume of 90,979. The business has a fifty day simple moving average of $2.87 and a 200 day simple moving average of $3.47. The company has a market cap of $144.61 million, a P/E ratio of 205.21 and a beta of 1.07. Solesence, Inc. has a fifty-two week low of $1.34 and a fifty-two week high of $16.56. The company has a current ratio of 1.84, a quick ratio of 0.78 and a debt-to-equity ratio of 0.61.
Solesence (NASDAQ:SLSN - Get Free Report) last announced its quarterly earnings results on Thursday, November 13th. The company reported ($0.02) EPS for the quarter. Solesence had a net margin of 1.72% and a return on equity of 6.53%. The firm had revenue of $14.60 million during the quarter.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in SLSN. Vanguard Group Inc. lifted its position in shares of Solesence by 10.8% in the 3rd quarter. Vanguard Group Inc. now owns 1,042,716 shares of the company's stock worth $3,358,000 after purchasing an additional 101,868 shares during the period. JPMorgan Chase & Co. raised its stake in Solesence by 106.8% during the third quarter. JPMorgan Chase & Co. now owns 18,379 shares of the company's stock worth $59,000 after buying an additional 9,491 shares during the last quarter. Modern Wealth Management LLC acquired a new position in Solesence in the second quarter valued at $119,000. Bank of America Corp DE bought a new stake in Solesence during the second quarter valued at $26,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in Solesence during the second quarter valued at $45,000. Institutional investors own 70.22% of the company's stock.
Analysts Set New Price Targets
Separately, Weiss Ratings reiterated a "sell (d)" rating on shares of Solesence in a research report on Monday. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of "Sell".
Read Our Latest Report on Solesence
About Solesence
(
Get Free Report)
Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
